The use of mometasone , expressed as both optimal adherence rate ( 48.4 % vs. 12.5 % ; P = 0.002 ) and average daily use ( 0.200.12 g/day vs. 0.150.07 g/day ; P = 0.037 ) , was higher in the AM group ( n = 31 ) than among controls ( n = 32 ) .